Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, Canada.

De Serres G, Billard MN, Gariépy MC, Rouleau I, Toth E, Landry M, Boulianne N, Gagné H, Gilca V, Deceuninck G, Ouakki M, Skowronski DM.

Vaccine. 2018 Dec 18;36(52):8039-8046. doi: 10.1016/j.vaccine.2018.10.095. Epub 2018 Nov 19.

PMID:
30467063
2.

Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec.

De Wals P, Lefebvre B, Deceuninck G, Longtin J.

Vaccine. 2018 Jan 8;36(3):421-426. doi: 10.1016/j.vaccine.2017.11.054. Epub 2017 Dec 7.

PMID:
29224962
3.

Absence of association between Guillain-Barré syndrome hospitalizations and HPV-vaccine.

Deceuninck G, Sauvageau C, Gilca V, Boulianne N, De Serres G.

Expert Rev Vaccines. 2018 Jan;17(1):99-102. doi: 10.1080/14760584.2018.1388168. Epub 2017 Oct 13.

PMID:
28972438
4.

Hospitalisation for lower respiratory tract infection in children in the province of Quebec, Canada, before and during the pneumococcal conjugate vaccine era.

Anderson G, Deceuninck G, Zhou Z, Boucher FD, Bonnier Viger Y, Gilca R, De Wals P.

Epidemiol Infect. 2017 Oct;145(13):2770-2776. doi: 10.1017/S0950268817001510. Epub 2017 Aug 14.

PMID:
28803551
5.

Forecasting Trends in Invasive Pneumococcal Disease among Elderly Adults in Quebec.

Zhou Z, Deceuninck G, Lefebvre B, De Wals P.

Can J Infect Dis Med Microbiol. 2017;2017:4347206. doi: 10.1155/2017/4347206. Epub 2017 Jan 26.

6.

Impact of an Immunization Campaign to Control an Increased Incidence of Serogroup B Meningococcal Disease in One Region of Quebec, Canada.

De Wals P, Deceuninck G, Lefebvre B, Tsang R, Law D, De Serres G, Gilca V, Gilca R, Boulianne N.

Clin Infect Dis. 2017 May 1;64(9):1263-1267. doi: 10.1093/cid/cix154.

PMID:
28207068
7.

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.

De Wals P, Deceuninck G, De Serres G.

Vaccine. 2016 Apr 19;34(18):2053-4. doi: 10.1016/j.vaccine.2015.06.104. No abstract available.

PMID:
27021043
8.

Parental Vaccine Hesitancy in Quebec (Canada).

Dubé E, Gagnon D, Zhou Z, Deceuninck G.

PLoS Curr. 2016 Mar 7;8. pii: ecurrents.outbreaks.9e239605f4d320c6ad27ce2aea5aaad2. doi: 10.1371/currents.outbreaks.9e239605f4d320c6ad27ce2aea5aaad2.

9.

Predictors of hospitalization for lower respiratory tract infection in children aged <2 years in the province of Quebec, Canada.

Zhou Z, Gilca R, Deceuninck G, Boucher FD, Charest H, DE Wals P.

Epidemiol Infect. 2016 Apr;144(5):1035-44. doi: 10.1017/S0950268815002204. Epub 2015 Sep 18.

PMID:
26381086
10.

Effectiveness of three pneumococcal conjugate vaccines to prevent invasive pneumococcal disease in Quebec, Canada.

Deceuninck G, De Serres G, Boulianne N, Lefebvre B, De Wals P.

Vaccine. 2015 May 28;33(23):2684-9. doi: 10.1016/j.vaccine.2015.04.005. Epub 2015 Apr 15.

PMID:
25887086
11.

Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec.

Montplaisir J, Petit D, Quinn MJ, Ouakki M, Deceuninck G, Desautels A, Mignot E, De Wals P.

PLoS One. 2014 Sep 29;9(9):e108489. doi: 10.1371/journal.pone.0108489. eCollection 2014.

12.

Pediatric Pleural Empyema in the Province of Quebec: Analysis of a 10-Fold Increase Between 1990 and 2007.

Deceuninck G, Quach C, Panagopoulos M, Thibeault R, Côté-Boileau T, Tapiéro B, Coïc L, De Wals P, Ovetchkine P.

J Pediatric Infect Dis Soc. 2014 Jun;3(2):119-26. doi: 10.1093/jpids/pit075. Epub 2013 Dec 6.

PMID:
26625364
13.

Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada.

De Wals P, Lefebvre B, Markowski F, Deceuninck G, Defay F, Douville-Fradet M, Landry M.

Vaccine. 2014 Mar 14;32(13):1501-6. doi: 10.1016/j.vaccine.2013.11.028. Epub 2014 Jan 31.

PMID:
24486346
14.

International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.

Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Gutierrez-Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Gimenez-Sanchez F, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H; Global H1N1 GBS Consortium.

Vaccine. 2013 Sep 13;31(40):4448-58. doi: 10.1016/j.vaccine.2013.06.032. Epub 2013 Jun 14.

PMID:
23770307
15.

A simulation study to compare three self-controlled case series approaches: correction for violation of assumption and evaluation of bias.

Hua W, Sun G, Dodd CN, Romio SA, Whitaker HJ, Izurieta HS, Black S, Sturkenboom MC, Davis RL, Deceuninck G, Andrews NJ.

Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):819-25. doi: 10.1002/pds.3451. Epub 2013 Apr 29.

PMID:
23625875
16.

Factors associated with HPV vaccination among adult women in Quebec.

Kiely M, Sauvageau C, Dubé E, Deceuninck G, De Wals P.

Hum Vaccin Immunother. 2013 Jul;9(7):1421-4. doi: 10.4161/hv.24603. Epub 2013 Apr 9.

17.

The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains.

Gilca R, Deceuninck G, Lefebvre B, Tsang R, Amini R, Gilca V, Douville-Fradet M, Markowski F, De Wals P.

PLoS One. 2012;7(11):e50659. doi: 10.1371/journal.pone.0050659. Epub 2012 Nov 29.

18.

Invasive pneumococcal diseases in birth cohorts vaccinated with PCV-7 and/or PHiD-CV in the province of Quebec, Canada.

De Wals P, Lefebvre B, Defay F, Deceuninck G, Boulianne N.

Vaccine. 2012 Oct 5;30(45):6416-20. doi: 10.1016/j.vaccine.2012.08.017. Epub 2012 Aug 21.

PMID:
22921290
19.

Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec.

De Wals P, Deceuninck G, Toth E, Boulianne N, Brunet D, Boucher RM, Landry M, De Serres G.

JAMA. 2012 Jul 11;308(2):175-81. doi: 10.1001/jama.2012.7342.

PMID:
22782419
20.

Invasive serogroup B Neisseria meningitidis in Quebec, Canada, 2003 to 2010: persistence of the ST-269 clone since it first emerged in 2003.

Zhou J, Lefebvre B, Deng S, Gilca R, Deceuninck G, Law DK, De Wals P, Tsang RS.

J Clin Microbiol. 2012 May;50(5):1545-51. doi: 10.1128/JCM.06835-11. Epub 2012 Feb 15.

21.

Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children.

Gilca R, Deceuninck G, De Serres G, Boulianne N, Sauvageau C, Quach C, Boucher FD, Skowronski DM.

Pediatrics. 2011 Nov;128(5):e1084-91. doi: 10.1542/peds.2010-3492. Epub 2011 Oct 10.

PMID:
21987710
22.

[Human papilloma virus: knowledge, beliefs and behavior of Quebec women].

Kiely M, Sauvageau C, Dubé E, Deceuninck G, De Wals P.

Can J Public Health. 2011 Jul-Aug;102(4):303-7. French.

PMID:
21913589
23.

Effectiveness of serogroup C meningococcal conjugate vaccine: a 7-year follow-up in Quebec, Canada.

De Wals P, Deceuninck G, Lefebvre B, Boulianne N, De Serres G.

Pediatr Infect Dis J. 2011 Jul;30(7):566-9. doi: 10.1097/INF.0b013e31820e8638.

PMID:
21326136
24.

Feasibility and impact of providing feedback to vaccinating medical clinics: evaluating a public health intervention.

Brousseau N, Sauvageau C, Ouakki M, Audet D, Kiely M, Couture C, Paré A, Deceuninck G.

BMC Public Health. 2010 Dec 3;10:750. doi: 10.1186/1471-2458-10-750.

25.

Uptake of pneumococcal conjugate vaccine: methodological issues in measurement and impact of publicly funded programs.

De Wals P, Boulianne N, Sévin E, Ouakki M, Deceuninck G, Guay M.

Can J Public Health. 2009 Nov-Dec;100(6):413-6.

PMID:
20209732
26.

Effectiveness of pneumococcal conjugate vaccine using a 2+1 infant schedule in Quebec, Canada.

Deceuninck G, De Wals P, Boulianne N, De Serres G.

Pediatr Infect Dis J. 2010 Jun;29(6):546-9. doi: 10.1097/INF.0b013e3181cffa2a.

PMID:
20125062
27.

Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine.

Gilca V, De Serres G, Boulianne N, De Wals P, Murphy D, Trudeau G, Deceuninck G, Massé R, Duval B.

Hum Vaccin. 2010 Feb;6(2):212-8. Epub 2010 Feb 11.

PMID:
19946212
28.

Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of Quebec, Canada.

Wals PD, Carbon M, Sévin E, Deceuninck G, Ouakki M.

Pediatr Infect Dis J. 2009 Sep;28(9):e271-5. doi: 10.1097/INF.0b013e3181bad212.

PMID:
19710582
29.

Analysis of mortality following a mass immunization campaign with serogroup C meningococcal conjugate vaccine: methodological difficulties and imperfect solutions.

De Wals P, Deceuninck G, Ouakki M, Boulianne N, De Serres G, Danzig L.

Vaccine. 2009 May 21;27(24):3223-7. doi: 10.1016/j.vaccine.2009.02.055. Epub 2009 Feb 24.

PMID:
19446195
30.

Epidemiology of Guillain-Barré syndrome in the province of Quebec.

Deceuninck G, Boucher RM, De Wals P, Ouakki M.

Can J Neurol Sci. 2008 Sep;35(4):472-5.

PMID:
18973064
31.

Factors predicting overall success: a review of 747 microsurgical vasovasostomies.

Bolduc S, Fischer MA, Deceuninck G, Thabet M.

Can Urol Assoc J. 2007 Nov;1(4):388-94.

32.

Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada.

De Wals P, Deceuninck G, Boucher RM, Ouakki M.

Clin Infect Dis. 2008 Apr 15;46(8):e75-7. doi: 10.1086/533469.

PMID:
18444843
33.

Opinions of Quebec parents and vaccinators on the usefulness of chickenpox vaccine.

Boulianne NA, Duval B, Serres GD, Deceuninck G, Dionne M, Carsley J, Valiquette L, Massé R.

Can J Infect Dis. 2001 May;12(3):153-6.

34.

Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.

Duval B, Gîlca V, Boulianne N, Deceuninck G, Rochette L, De Serres G.

Vaccine. 2005 Jul 1;23(31):4082-7. Epub 2004 Aug 9.

PMID:
15963363
35.

Effectiveness of serogroup C meningococcal polysaccharide vaccine: results from a case-control study in Quebec.

De Wals P, Deceuninck G, De Serres G, Boivin JF, Duval B, Remis R, Massé R.

Clin Infect Dis. 2005 Apr 15;40(8):1116-22. Epub 2005 Mar 11.

PMID:
15791510
36.

Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine.

De Wals P, Deceuninck G, Boulianne N, De Serres G.

JAMA. 2004 Nov 24;292(20):2491-4.

PMID:
15562128
37.

[Why are some children incompletely vaccinated at the age of 2?].

Boulianne N, Deceuninck G, Duval B, Lavoie F, Dionne M, Carsley J, Valiquette L, Rochette L, De Serres G.

Can J Public Health. 2003 May-Jun;94(3):218-23. French.

PMID:
12790498
38.

Seroprotection rates after late doses of hepatitis B vaccine.

Duval B, Deceuninck G.

Pediatrics. 2002 Feb;109(2):350-1. No abstract available.

PMID:
11826227
39.

Most ten-year-old children with negative or unknown histories of chickenpox are immune.

Boulianne N, Duval B, De Serres G, Deceuninck G, Massé R, Couillard M.

Pediatr Infect Dis J. 2001 Nov;20(11):1087-8.

PMID:
11734718
40.

HIV infection among sex workers in Accra: need to target new recruits entering the trade.

Asamoah-Adu C, Khonde N, Avorkliah M, Bekoe V, Alary M, Mondor M, Frost E, Deceuninck G, Asamoah-Adu A, Pépin J.

J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):358-66.

PMID:
11707673
41.

Improvement of clinical algorithms for the diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis by the use of Gram-stained smears among female sex workers in Accra, Ghana.

Deceuninck G, Asamoah-Adu C, Khonde N, Pépin J, Frost EH, Deslandes S, Asamoah-Adu A, Bekoe V, Alary M.

Sex Transm Dis. 2000 Aug;27(7):401-10.

PMID:
10949431

Supplemental Content

Loading ...
Support Center